Shire Dev., LLC v. Watson Pharm., Inc., 14–206.

• Decision Date: 26 January 2015
• Docket Number: No. 14–206.,14–206.
• Citation: 191 L.Ed.2d 130,135 S.Ct. 1174 (Mem)
• Parties: SHIRE DEVELOPMENT, LLC, et al., petitioners, v. WATSON PHARMACEUTICALS, INC., et al.
• Court: U.S. Supreme Court

135 S.Ct. 1174 (Mem)

191 L.Ed.2d 130

SHIRE DEVELOPMENT, LLC, et al., petitioners,

v.WATSON PHARMACEUTICALS, INC., et al.

No. 14–206.

Supreme Court of the United States

Jan. 26, 2015.

Opinion

On petition for writ of certiorari to the United States Court of Appeals for the Federal Circuit. Petition for writ of certiorari granted. Judgment vacated, and case remanded to the United States Court of Appeals for the Federal Circuit for further consideration in light of Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc.,574 U.S. ––––, 135 S.Ct. 831, ––– L.Ed.2d –––– (2015).